Salvatore Pernagallo

Prof. Salvatore Pernagallo

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2013 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
CMClaire N. Medine
Claire N. Medine
BLBaltasar Lucendo-Villarin
Baltasar Lucendo-Villarin
CSChristopher Storck
Christopher Storck
FWFaye Wang
Faye Wang
Dagmara SzkolnickaDagmara Szkolnicka
Dagmara Szkolnicka
David HayDavid Hay
David Hay
Faithfully recapitulating human physiology “in a dish” from a renewable source remains a holy grail for medicine and pharma. Many procedures have been described that, to a limited extent, exhibit human tissue-specific function in vitro. In particular, incomplete cellular differentiation and/or the loss of cell phenotype postdifferentiation play a major part in this void. We have developed an interdisciplinary approach to address this problem, using skill sets in cell biology, materials chemistry, and pharmacology. Pluripotent stem cells were differentiated to hepatocytes before being replated onto a synthetic surface. Our approach yielded metabolically active hepatocyte populations that displayed stable function for more than 2 weeks in vitro. Although metabolic activity was an important indication of cell utility, the accurate prediction of cellular toxicity in response to specific pharmacological compounds represented our goal. Therefore, detailed analysis of hepatocellular toxicity was performed in response to a custom-built and well-defined compound set and compared with primary human hepatocytes. Importantly, stem cell-derived hepatocytes displayed equivalence to primary human material. Moreover, we demonstrated that our approach was capable of modeling metabolic differences observed in the population. In conclusion, we report that pluripotent stem cell-derived hepatocytes will model toxicity predictably and in a manner comparable to current gold standard assays, representing a major advance in the field.

1 March 2011 in Stem Cell Research
Verified
Journal Article
Closed access
David HayDavid Hay
David Hay
Salvatore PernagalloSalvatore Pernagallo
Salvatore Pernagallo
JDJuan Díaz-mochon
Juan Díaz-mochon
CMClaire N. Medine
Claire N. Medine
SGSebastian Greenhough
Sebastian Greenhough
JIJohn P. Iredale
John P. Iredale

1 November 2013 in Current Biology
Verified
Journal Article
Open access
ALAlessandra Livigni
Alessandra Livigni
HPHanna Peradziryi
Hanna Peradziryi
ASAlexei A. Sharov
Alexei A. Sharov
GCGloryn Chia
Gloryn Chia
FHFella Hammachi
Fella Hammachi
JBJoshua M. Brickman
Joshua M. Brickman
The class V POU domain transcription factor Oct4 (Pou5f1) is a pivotal regulator of embryonic stem cell (ESC) self-renewal and reprogramming of somatic cells to induced pluripotent stem (iPS) cells. Oct4 is also an important evolutionarily conserved regulator of progenitor cell differentiation during embryonic development. Here we examine the function of Oct4 homologs in Xenopus embryos and compare this to the role of Oct4 in maintaining mammalian embryo-derived stem cells. Based on a combination of expression profiling of Oct4/POUV-depleted Xenopus embryos and in silico analysis of existing mammalian Oct4 target data sets, we defined a set of evolutionary-conserved Oct4/POUV targets. Most of these targets were regulators of cell adhesion. This is consistent with Oct4/POUV phenotypes observed in the adherens junctions in Xenopus ectoderm, mouse embryonic, and epiblast stem cells. A number of these targets could rescue both Oct4/POUV phenotypes in cellular adhesion and multipotent progenitor cell maintenance, whereas expression of cadherins on their own could only transiently support adhesion and block differentiation in both ESC and Xenopus embryos. Currently, the list of Oct4 transcriptional targets contains thousands of genes. Using evolutionary conservation, we identified a core set of functionally relevant factors that linked the maintenance of adhesion to Oct4/POUV. We found that the regulation of adhesion by the Oct4/POUV network occurred at both transcriptional and posttranslational levels and was required for pluripotency.

5 July 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DRDavid M. Rissin
David M. Rissin
BLBarbara López-Longarela
Barbara López-Longarela
Salvatore PernagalloSalvatore Pernagallo
Salvatore Pernagallo
HIHugh Ilyine
Hugh Ilyine
AVA. D. Bastiaan Vliegenthart
A. D. Bastiaan Vliegenthart
DDDavid C. Duffy
David C. Duffy
We have developed a single probe method for detecting microRNA from human serum using single molecule arrays, with sequence specificity down to a single base, and without the use of amplification by polymerases. An abasic peptide nucleic acid (PNA) probe—containing a reactive amine instead of a nucleotide at a specific position in the sequence—for detecting a microRNA was conjugated to superparamagnetic beads. These beads were incubated with a sample containing microRNA, a biotinylated reactive nucleobase—containing an aldehyde group—that was complementary to the missing base in the probe sequence, and a reducing agent. When a target molecule with an exact match in sequence hybridized to the capture probe, the reactive nucleobase was covalently attached to the backbone of the probe by a dynamic covalent chemical reaction. Single molecules of the biotin-labeled probe were then labeled with streptavidin-β-galactosidase (SβG), the beads were resuspended in a fluorogenic enzyme substrate, loaded into an array of femtoliter wells, and sealed with oil. The array was imaged fluorescently to determine which beads were associated with single enzymes, and the average number of enzymes per bead was determined. The assay had a limit of detection of 500 fM, approximately 500 times more sensitive than a corresponding analog bead-based assay, with target specificity down to a single base mis-match. This assay was used to measure microRNA-122 (miR-122)—an established biomarker of liver toxicity—extracted from the serum of patients who had acute liver injury due to acetaminophen, and control healthy patients. All patients with liver injury had higher levels of miR-122 in their serum compared to controls, and the concentrations measured correlated well with those determined using RT-qPCR. This approach allows rapid quantification of circulating microRNA with single-based specificity and a limit of quantification suitable for clinical use.

15 January 2020 in Analytical Chemistry
Verified
Journal Article
Closed access
BLBarbara López-Longarela
Barbara López-Longarela
EMEmma E. Morrison
Emma E. Morrison
JTJohn D. Tranter
John D. Tranter
LCLianne Chahman-Vos
Lianne Chahman-Vos
JLJean-François Léonard
Jean-François Léonard
JDJuan Díaz-mochon
Juan Díaz-mochon

1 February 2010 in Journal of Neurotrauma
Verified
Journal Article
Closed access
VPValentina Di Pietro
Valentina Di Pietro
DADaven Amin
Daven Amin
Salvatore PernagalloSalvatore Pernagallo
Salvatore Pernagallo
Giuseppe LazzarinoGiuseppe Lazzarino
Giuseppe Lazzarino
Barbara TavazziBarbara Tavazzi
Barbara Tavazzi
ABAntonio Belli
Antonio Belli
Traumatic brain injury (TBI) is the one of the most common forms of head trauma, and it remains a leading cause of death and disability. It is known that the initial mechanical axonal injury triggers a complex cascade of neuroinflammatory and metabolic events, the understanding of which is essential for clinical, translational, and pharmacological research. These can occur even in mild TBI, and are associated with several post-concussion manifestations, including transiently heightened vulnerability to a second insult. Recent studies have challenged the tenet that ischemia is the ultimate modality of tissue damage following TBI, as metabolic dysfunction can develop in the presence of normal perfusion and before intracranial hypertension. In order to elucidate the cellular and molecular changes occurring in TBI as a direct result of neuronal injury and in the absence of ischemic damage, we performed a microarray analysis of expressed genes and molecular interaction pathways for different levels of severity of trauma using an in-vitro model. A stretch injury, equivalent to human diffuse axonal injury, was delivered to rat organotypic hippocampal slice cultures, and mRNA levels following a 10% (mild) and 50% (severe) stretch were compared with controls at 24 h. More genes were differentially expressed following 10% stretch than 50% stretch, indicating the early activation of complex cellular mechanisms. The data revealed remarkable differential gene expression following mTBI, even in the absence of cell damage. Pathway analysis revealed that molecular interactions in both levels of injury were similar, with IL-1beta playing a central role. Additional pathways of neurodegeneration involving RhoA (ras homolog gene family, member A) were found in 50% stretch.